Exact Mass: 289.2213

Exact Mass Matches: 289.2213

Found 122 metabolites which its exact mass value is equals to given mass value 289.2213, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dyclonine

1-(4-butoxyphenyl)-3-(piperidin-1-yl)propan-1-one

C18H27NO2 (289.2042)


Dyclonine is only found in individuals that have used or taken this drug. It is an oral anaesthetic found in Sucrets, an over the counter throat lozenge. It is also found in some varieties of the Cepacol sore throat spray.Dyclonine blocks both the initiation and conduction of nerve impulses by decreasing the neuronal membranes permeability to sodium ions. This reversibly stabilizes the membrane and inhibits depolarization, resulting in the failure of a propagated action potential and subsequent conduction blockade. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AD - Anesthetics, local D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

NCIOpen2_002582

17a-Aza-D-homoandrost-5-en-3beta-ol

C19H31NO (289.2406)


   

N-(2-Hydroxyisobutyl)-2,4,8,10,12-tetradecapentaenamide

(2E,4E,8E,10E,12E)-N-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide

C18H27NO2 (289.2042)


Hydroxy-gamma-sanshool is found in herbs and spices. Hydroxy-gamma-sanshool is a constituent of Zanthoxylum piperitum (Japanese pepper tree) Constituent of Zanthoxylum subspecies N-(2-Hydroxyisobutyl)-2,4,8,10,12-tetradecapentaenamide is found in herbs and spices.

   

Dihydro-2,4,6-tris(2-methylpropyl)-4h-1,3,5-dithiazine

1,3,5-Dithiazine, perhydro-2,4-dimethyl-6-(1-methylethyl)

C15H31NS2 (289.1898)


Dihydro-2,4,6-tris(2-methylpropyl)-4h-1,3,5-dithiazine is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")

   

3-Hydroxyheptanoylcarnitine

3-[(3-Hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C14H27NO5 (289.1889)


3-hydroxyheptanoylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyheptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyheptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyheptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxyheptanoylcarnitine

3-[(5-hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO5 (289.1889)


5-hydroxyheptanoylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxyheptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-hydroxyheptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-hydroxyheptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Hydroxyheptanoylcarnitine

3-[(4-hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO5 (289.1889)


4-hydroxyheptanoylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxyheptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-hydroxyheptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-hydroxyheptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Hydroxyheptanoylcarnitine

3-[(6-Hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C14H27NO5 (289.1889)


6-hydroxyheptanoylcarnitine is an acylcarnitine. More specifically, it is an 6-hydroxyheptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-hydroxyheptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-hydroxyheptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2R,3R,4R,5S)-2-(Hydroxymethyl)-1-nonylpiperidine-3,4,5-triol

(2R,3R,4R,5S)-2-(Hydroxymethyl)-1-nonylpiperidine-3,4,5-triol

C15H31NO4 (289.2253)


   

Dimethylphysostigmine

1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N,N-dimethylcarbamate

C16H23N3O2 (289.179)


   

Aminohexane

2-[(dimethylamino)methyl]-1-ethylcyclohexyl benzoate

C18H27NO2 (289.2042)


   

BENCYCLANE

Andreu brand OF bencyclane acefyllinate and fumarate

C19H31NO (289.2406)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

Caramiphen

2-(Diethylamino)ethyl 1-phenylcyclopentane-1-carboxylic acid

C18H27NO2 (289.2042)


C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent

   

trimethylamino-diphenylhexatriene

3,4,5-trimethyl-1,1-diphenylhexa-1,3,5-trien-2-amine

C21H23N (289.183)


   

trimethylaminodiphenylhexatriene

2,3,6-trimethyl-4-(1-phenylhexa-1,3,5-trien-1-yl)aniline

C21H23N (289.183)


   

WS-12

N-(4-methoxyphenyl)-5-methyl-2-(propan-2-yl)cyclohexane-1-carboxamide

C18H27NO2 (289.2042)


   

4-Methoxy-alpha-phpp

4-Methoxy-alpha-phpp

C18H27NO2 (289.2042)


   

Dihydrogephyrotoxin

Dihydrogephyrotoxin

C19H31NO (289.2406)


   
   
   

2-(hexadec-13-ene-9,11-diynyl-methylamino)ethanol

2-(hexadec-13-ene-9,11-diynyl-methylamino)ethanol

C19H31NO (289.2406)


   

1-[(2E,4E,8Z)-tetradeca-2,4,8-trienoyl]piperidine|N-[(2E,4E,8Z)-tetradecatrienoyl]piperidine

1-[(2E,4E,8Z)-tetradeca-2,4,8-trienoyl]piperidine|N-[(2E,4E,8Z)-tetradecatrienoyl]piperidine

C19H31NO (289.2406)


   

alpha-1-C-(8-hydroxyoctyl)-1-deoxynojirimycin

alpha-1-C-(8-hydroxyoctyl)-1-deoxynojirimycin

C15H31NO4 (289.2253)


   

2-Amino-1,3,4-hexadecanetriol

2-Amino-1,3,4-hexadecanetriol

C16H35NO3 (289.2617)


   

(Xi)-1-[(2Xi)-6c-((Xi)-beta-Hydroxy-phenaethyl)-1-methyl-1,2,3,6-tetrahydro-[2r]pyridyl]-butan-2-ol|(Xi)-1-[(2Xi)-6c-((Xi)-beta-hydroxy-phenethyl)-1-methyl-1,2,3,6-tetrahydro-[2r]pyridyl]-butan-2-ol|1-[6-(beta-Hydroxy-phenaethyl)-1-methyl-1,2,3,6-tetrahydro-[2]pyridyl]-butan-2-ol

(Xi)-1-[(2Xi)-6c-((Xi)-beta-Hydroxy-phenaethyl)-1-methyl-1,2,3,6-tetrahydro-[2r]pyridyl]-butan-2-ol|(Xi)-1-[(2Xi)-6c-((Xi)-beta-hydroxy-phenethyl)-1-methyl-1,2,3,6-tetrahydro-[2r]pyridyl]-butan-2-ol|1-[6-(beta-Hydroxy-phenaethyl)-1-methyl-1,2,3,6-tetrahydro-[2]pyridyl]-butan-2-ol

C18H27NO2 (289.2042)


   

3-isopropenyl-7,7-dimethyl-8-(3-methyl-but-2-enoyl)-2,6,7,8-tetrahydro-3H-imidazo[1,2-a]pyrimidin-5-one|Alchornidin|Alchornidine

3-isopropenyl-7,7-dimethyl-8-(3-methyl-but-2-enoyl)-2,6,7,8-tetrahydro-3H-imidazo[1,2-a]pyrimidin-5-one|Alchornidin|Alchornidine

C16H23N3O2 (289.179)


   
   

N-(2-Hydroxyisobutyl)-2,4,8,10,12-tetradecapentaenamide

2,4,8,10,12-Tetradecapentaenamide, N-(2-hydroxy-2-methylpropyl)-, (2E,4E,8E,10E,12E)-

C18H27NO2 (289.2042)


N-(2-Hydroxyisobutyl)-2,4,8,10,12-tetradecapentaenamide is a fatty amide. (2E,4E,8E,10E,12E)-N-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide is a natural product found in Zanthoxylum bungeanum with data available. Hydroxy-gamma-sanshool is found in herbs and spices. Hydroxy-gamma-sanshool is a constituent of Zanthoxylum piperitum (Japanese pepper tree) Constituent of Zanthoxylum subspecies N-(2-Hydroxyisobutyl)-2,4,8,10,12-tetradecapentaenamide is found in herbs and spices.

   

CYPROHEPTADINE

CYPROHEPTADINE

C21H23N (289.183)


   

(8S,Z)-6-((R,4E,6E)-2,5-dimethylocta-4,6-dien-1-ylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((R,4E,6E)-2,5-dimethylocta-4,6-dien-1-ylidene)-8-methyloctahydroindolizin-8-ol

C19H31NO (289.2406)


   

(7R,E)-4,7-dimethyl-8-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)oct-4-en-3-one

(7R,E)-4,7-dimethyl-8-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)oct-4-en-3-one

C19H31NO (289.2406)


   

2-((1S,3aS,6S)-6-((E)-penta-2,4-dien-1-yl)dodecahydropyrrolo[1,2-a]quinolin-1-yl)ethan-1-ol

2-((1S,3aS,6S)-6-((E)-penta-2,4-dien-1-yl)dodecahydropyrrolo[1,2-a]quinolin-1-yl)ethan-1-ol

C19H31NO (289.2406)


   

Hydroxy-g-isosanshool

(2E,4E,8E,10E,12E)-N-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide

C18H27NO2 (289.2042)


   

Triisobutyldihydrodithiazine

1,3,5-Dithiazine, perhydro-2,4-dimethyl-6-(1-methylethyl)

C15H31NS2 (289.1898)


   

NA 18:5;O

2-hydroxy-N-(isobutyl)-tetradeca-2E,4E,8Z,10E,12E-pentaenamide

C18H27NO2 (289.2042)


   

1-Phenoxy-5,5-dimethyl-3-(1H-1,2,4-triazol-1-yl)-4-hexanol

1-Phenoxy-5,5-dimethyl-3-(1H-1,2,4-triazol-1-yl)-4-hexanol

C16H23N3O2 (289.179)


   

N,N-BIS(T-BUTYL-4-CARBOXYMETHYL)AMINOETHANOL

N,N-BIS(T-BUTYL-4-CARBOXYMETHYL)AMINOETHANOL

C14H27NO5 (289.1889)


   

Butaverine

Butaverine

C18H27NO2 (289.2042)


C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE

BENZYL 4-(PYRROLIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE

C16H23N3O2 (289.179)


   

1-λ1-oxidanyl-2,2,5,5-tetramethyl-N-(1,3,4-trihydroxybutan-2-yl)pyrrolidine-3-carboxamide

1-λ1-oxidanyl-2,2,5,5-tetramethyl-N-(1,3,4-trihydroxybutan-2-yl)pyrrolidine-3-carboxamide

C13H25N2O5 (289.1763)


   

4-Morpholinophenylboronic Acid Pinacol Ester

4-Morpholinophenylboronic Acid Pinacol Ester

C16H24BNO3 (289.1849)


   

1-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZINE

1-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZINE

C15H24BN3O2 (289.1961)


   

(1-methylpiperidin-4-yl) 3-methyl-2-phenylpentanoate

(1-methylpiperidin-4-yl) 3-methyl-2-phenylpentanoate

C18H27NO2 (289.2042)


   

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZINE

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZINE

C15H24BN3O2 (289.1961)


   

tert-butyl N-[1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]carbamate

tert-butyl N-[1-[tert-butyl(dimethyl)silyl]oxypropan-2-yl]carbamate

C14H31NO3Si (289.2073)


   

decanal / methyl anthranilate schiffs base

decanal / methyl anthranilate schiffs base

C18H27NO2 (289.2042)


   
   

N-CYCLOPENTYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIMIDIN-2-AMINE

N-CYCLOPENTYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIMIDIN-2-AMINE

C15H24BN3O2 (289.1961)


   

N-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]butan-1-amine

N-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]butan-1-amine

C17H28BNO2 (289.2213)


   

1H-Pyrrolo[2,3-b]pyridin-5-amine, 1-[tris(1-methylethyl)silyl]-

1H-Pyrrolo[2,3-b]pyridin-5-amine, 1-[tris(1-methylethyl)silyl]-

C16H27N3Si (289.1974)


   

N,N-dimethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide

N,N-dimethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide

C16H24BNO3 (289.1849)


   

N-ethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide

N-ethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide

C16H24BNO3 (289.1849)


   

2-piperizinylpyridine-4-boronic acid, pinacol ester

2-piperizinylpyridine-4-boronic acid, pinacol ester

C15H24BN3O2 (289.1961)


   

N-Acetyl-3-(4-(p-methoxyphenyl)piperazinyl)azetidine

N-Acetyl-3-(4-(p-methoxyphenyl)piperazinyl)azetidine

C16H23N3O2 (289.179)


   
   

taclamine

taclamine

C21H23N (289.183)


   

Tributylphosphonium tetrafluoroborate

Tributylphosphonium tetrafluoroborate

C12H27BF4P (289.1879)


   

2-(CYCLOPENTYLOXY)-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

2-(CYCLOPENTYLOXY)-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

C16H24BNO3 (289.1849)


   

N,N,4-trimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

N,N,4-trimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C16H24BNO3 (289.1849)


   

2-(CYCLOPENTYLOXY)-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

2-(CYCLOPENTYLOXY)-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

C16H24BNO3 (289.1849)


   

3-(azepan-1-yl)-1-(4-propoxyphenyl)propan-1-one

3-(azepan-1-yl)-1-(4-propoxyphenyl)propan-1-one

C18H27NO2 (289.2042)


   

2-(piperidin-1-yl)pyrimidine-5-boronic acid pinacol ester

2-(piperidin-1-yl)pyrimidine-5-boronic acid pinacol ester

C15H24BN3O2 (289.1961)


   

3-oxododecanoic acid glyceride

3-oxododecanoic acid glyceride

C15H29O5- (289.2015)


   
   

DIHYDROXYETHYL LAURAMINE OXIDE

DIHYDROXYETHYL LAURAMINE OXIDE

C16H35NO3 (289.2617)


   

3-morpholinophenylboronic acid pinacol ester

3-morpholinophenylboronic acid pinacol ester

C16H24BNO3 (289.1849)


   

2-(3,5-Dimethylphenyl)-5-Isobutylquinoline

2-(3,5-Dimethylphenyl)-5-Isobutylquinoline

C21H23N (289.183)


   

α-[2-(Diethylamino)ethyl]-α-phenylcyclohexanemethanol

α-[2-(Diethylamino)ethyl]-α-phenylcyclohexanemethanol

C19H31NO (289.2406)


   

(TETRAMETHYLPIPERIDINYL)OXYPROPYLMETHYLSILOXANE-DIMETHYLSILOXANE COPOLYMER, TRIMETHYLSILOXY TERMINATED

(TETRAMETHYLPIPERIDINYL)OXYPROPYLMETHYLSILOXANE-DIMETHYLSILOXANE COPOLYMER, TRIMETHYLSILOXY TERMINATED

C13H31NO2Si2 (289.1893)


   
   

N,N-Dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

N,N-Dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

C16H24BNO3 (289.1849)


   

N-Ethyl-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)ethanamine

N-Ethyl-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)ethanamine

C17H28BNO2 (289.2213)


   

N-Ethyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)ethanamine

N-Ethyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)ethanamine

C17H28BNO2 (289.2213)


   

(1-PIPERIDIN-4-YL-AZETIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER

(1-PIPERIDIN-4-YL-AZETIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER

C16H23N3O2 (289.179)


   

(1-PIPERIDIN-3-YL-AZETIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER

(1-PIPERIDIN-3-YL-AZETIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER

C16H23N3O2 (289.179)


   

benzyl N-[(1-pyrrolidin-3-ylazetidin-3-yl)methyl]carbamate

benzyl N-[(1-pyrrolidin-3-ylazetidin-3-yl)methyl]carbamate

C16H23N3O2 (289.179)


   

(2R,3R,4R,5S)-2-(Hydroxymethyl)-1-nonylpiperidine-3,4,5-triol

(2R,3R,4R,5S)-2-(Hydroxymethyl)-1-nonylpiperidine-3,4,5-triol

C15H31NO4 (289.2253)


D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors D004791 - Enzyme Inhibitors N-Nonyldeoxynojirimycin (NN-DNJ) is a potent inhibitor of alpha-glucosidase and alpha-1,6-glucosidase (IC50s, 0.42, 8.4 μM, respectively), inhibits glycogen breakdown[1].

   

(4As,4br,8s,10ar,10bs,12as)-10a,12a-dimethyl-1,2,3,4,4a,4b,5,7,8,9,10,10a,10b,11,12,12a-hexadecahydronaphtho[2,1-f]quinolin-8-ol

(4As,4br,8s,10ar,10bs,12as)-10a,12a-dimethyl-1,2,3,4,4a,4b,5,7,8,9,10,10a,10b,11,12,12a-hexadecahydronaphtho[2,1-f]quinolin-8-ol

C19H31NO (289.2406)


   

6-(Cyclohexylmethoxy)-8-isopropyl-9H-purin-2-amine

6-(Cyclohexylmethoxy)-8-isopropyl-9H-purin-2-amine

C15H23N5O (289.1903)


   

Benzcyclane

Benzcyclane

C19H31NO (289.2406)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

1,3,4-Trihydroxy-2-amino-hexadecane

1,3,4-Trihydroxy-2-amino-hexadecane

C16H35NO3 (289.2617)


   

(2R,3R,4R,5S)-2-(Hydroxymethyl)-1-nonylpiperidine-3,4,5-triol

(2R,3R,4R,5S)-2-(Hydroxymethyl)-1-nonylpiperidine-3,4,5-triol

C15H31NO4 (289.2253)


   

trimethylaminodiphenylhexatriene

trimethylaminodiphenylhexatriene

C21H23N (289.183)


   

trimethylamino-diphenylhexatriene

trimethylamino-diphenylhexatriene

C21H23N (289.183)


   

5-Hydroxyheptanoylcarnitine

5-Hydroxyheptanoylcarnitine

C14H27NO5 (289.1889)


   

4-Hydroxyheptanoylcarnitine

4-Hydroxyheptanoylcarnitine

C14H27NO5 (289.1889)


   

6-Hydroxyheptanoylcarnitine

6-Hydroxyheptanoylcarnitine

C14H27NO5 (289.1889)


   

(2S,3S,4R)-2-aminohexadecane-1,3,4-triol

(2S,3S,4R)-2-aminohexadecane-1,3,4-triol

C16H35NO3 (289.2617)


   

10-ethyl-5,6,7,8-tetrahydrospiro[4a,8-(methanoiminomethano)quinazoline-2,1-cyclohexan]-4(3H)-one

10-ethyl-5,6,7,8-tetrahydrospiro[4a,8-(methanoiminomethano)quinazoline-2,1-cyclohexan]-4(3H)-one

C17H27N3O (289.2154)


   

1-[4-(2-Methylpropoxy)phenyl]-3-(1-piperidinyl)-1-propanone

1-[4-(2-Methylpropoxy)phenyl]-3-(1-piperidinyl)-1-propanone

C18H27NO2 (289.2042)


   

4-tert-butyl-N-[2-(2-methoxyphenyl)ethyl]-1-cyclohexanamine

4-tert-butyl-N-[2-(2-methoxyphenyl)ethyl]-1-cyclohexanamine

C19H31NO (289.2406)


   

1-Butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium

1-Butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium

C18H29N2O+ (289.228)


   

(1S,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C16H23N3O2 (289.179)


   

(1S,2aR,8bR)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aR,8bR)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C16H23N3O2 (289.179)


   

(1R,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aS,8bS)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C16H23N3O2 (289.179)


   

(1R,2aR,8bR)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aR,8bR)-1-(hydroxymethyl)-4-methyl-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C16H23N3O2 (289.179)


   

Levobupivacaine(1+)

Levobupivacaine(1+)

C18H29N2O+ (289.228)


   

Dextrobupivacaine(1+)

Dextrobupivacaine(1+)

C18H29N2O+ (289.228)


   

An isonitrile lipopetide

An isonitrile lipopetide

C12H25N4O4+ (289.1876)


   

2-(3-(4-N,N-Dimethylaminophenyl)propyl)naphthalene

2-(3-(4-N,N-Dimethylaminophenyl)propyl)naphthalene

C21H23N (289.183)


   

dyclonine

dyclonine

C18H27NO2 (289.2042)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AD - Anesthetics, local D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

Hydroxy-gamma-sanshool

Hydroxy-gamma-sanshool

C18H27NO2 (289.2042)


   

caramiphen

caramiphen

C18H27NO2 (289.2042)


C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent

   

3-Hydroxyheptanoylcarnitine

3-Hydroxyheptanoylcarnitine

C14H27NO5 (289.1889)


   

17a-Aza-D-homoandrost-5-en-3beta-ol

17a-Aza-D-homoandrost-5-en-3beta-ol

C19H31NO (289.2406)


   

Sphingosine (t16:0)

SPH(t16:0)

C16H35NO3 (289.2617)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

(2e,4e,8z)-1-(piperidin-1-yl)tetradeca-2,4,8-trien-1-one

(2e,4e,8z)-1-(piperidin-1-yl)tetradeca-2,4,8-trien-1-one

C19H31NO (289.2406)


   

(2e,4e,8z,10e,12e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

(2e,4e,8z,10e,12e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

C18H27NO2 (289.2042)


   

n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

C18H27NO2 (289.2042)


   

3-methyl-6-(3-methylocta-2,5-dien-1-yl)-5-propylpyridine-2,4-diol

3-methyl-6-(3-methylocta-2,5-dien-1-yl)-5-propylpyridine-2,4-diol

C18H27NO2 (289.2042)


   

7,7-dimethyl-8-(3-methylbut-2-enoyl)-3-(prop-1-en-2-yl)-2h,3h,6h-imidazo[1,2-a]pyrimidin-5-one

7,7-dimethyl-8-(3-methylbut-2-enoyl)-3-(prop-1-en-2-yl)-2h,3h,6h-imidazo[1,2-a]pyrimidin-5-one

C16H23N3O2 (289.179)


   

(2s,3s,5r)-2-benzyl-5-heptyl-1-methylpyrrolidin-3-ol

(2s,3s,5r)-2-benzyl-5-heptyl-1-methylpyrrolidin-3-ol

C19H31NO (289.2406)


   

9-[(2e)-hex-2-en-1-yl]-6-imino-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8(12)-en-9-ol

9-[(2e)-hex-2-en-1-yl]-6-imino-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8(12)-en-9-ol

C17H27N3O (289.2154)


   

(2e,4e,8e,10e,12e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

(2e,4e,8e,10e,12e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

C18H27NO2 (289.2042)


   

(3r)-7,7-dimethyl-8-(3-methylbut-2-enoyl)-3-(prop-1-en-2-yl)-2h,3h,6h-imidazo[1,2-a]pyrimidin-5-one

(3r)-7,7-dimethyl-8-(3-methylbut-2-enoyl)-3-(prop-1-en-2-yl)-2h,3h,6h-imidazo[1,2-a]pyrimidin-5-one

C16H23N3O2 (289.179)


   

1-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]butan-2-one

1-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]butan-2-one

C18H27NO2 (289.2042)


   

3-methyl-6-[(2e,5e)-3-methylocta-2,5-dien-1-yl]-5-propylpyridine-2,4-diol

3-methyl-6-[(2e,5e)-3-methylocta-2,5-dien-1-yl]-5-propylpyridine-2,4-diol

C18H27NO2 (289.2042)


   

1-[(2s,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]butan-2-one

1-[(2s,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]butan-2-one

C18H27NO2 (289.2042)


   

2-benzyl-5-heptyl-1-methylpyrrolidin-3-ol

2-benzyl-5-heptyl-1-methylpyrrolidin-3-ol

C19H31NO (289.2406)